BioClinica

Sanofi selects Bioclinca’s Onpoint as enterprise CTMS

Monday, October 1, 2012 02:15 PM

Pharmaceutical company Sanofi has selected global provider of clinical trial management services BioClinica’s OnPoint as the company’s standard clinical trial management system (CTMS). With this decision, Sanofi plans to utilize OnPoint CTMS for all clinical trial management activity.

More... »


BioClinica, Mirada partner for molecular image analysis

Monday, April 2, 2012 06:35 AM

Through a newly formed partnership, BioClinica, a global provider of clinical trial management solutions, will integrate Oxford-based Mirada Medical's XD3 software solution into its imaging core lab technology to enhance its PET capabilities and expertise for molecular imaging trials.

More... »


BioClinica, NextDocs to streamline trial submission process

Saturday, March 24, 2012 03:58 AM

BioClinica, a global provider of clinical trial management solutions, has partnered with NextDocs, a global provider of compliance solutions, to deliver solutions for easier access to clinical trial information and decrease the timeline for FDA submissions.

More... »

Onconova extends agreement with BioClinica

Wednesday, November 30, 2011 02:54 PM
BioClinica has reported that Onconova Therapeutics has extended agreements using BioClinica Express electronic data capture (EDC) and data management services to support their clinical trials world-wide. Onconova has a number of clinical-stage products and a growing number of pre-clinical candidates. These development stage compounds are novel small molecules for the treatment of a broad range of hematologic malignancies and solid tumors.

More... »

BioClinica inks seven with Trident IWR

Monday, April 18, 2011 11:55 AM

Pennsylvania-based BioClinica, a provider of clinical trial management solutions, has been selected by seven new clients for the use of BioClinica’s Trident IWR (interactive web response) to help build and deploy clinical trials without the need for programming.

More... »

BioClinica stockholder calls for executives to resign, as CEO says new eclinical push still ramping up

Tuesday, October 26, 2010 09:06 AM

White-hot controversy has been brewing between the imaging-focused CRO/eclinical company BioClinica and one of its investors, Nicusa Capital.

More... »

BioClinica Reports Flat Earnings, Adjusts 2010 EPS Guidance

Wednesday, May 5, 2010 01:07 PM

BioClinica’s first quarter 2010 earnings were flat compared with the same period 2009, with service revenues of $14.7 million. First quarter revenues last year were $14.5 million. Net income was $711,000, or $0.05 per diluted share, compared with $786,000, or $0.05 per diluted share for Q1 2009.

More... »

Oracle to Acquire Phase Forward for $685M

Friday, April 16, 2010 02:37 PM

Business software giant Oracle, already a player in the eClinical space, plans to acquire market leader Phase Forward in a deal valued at approximately $685 million—or $17 per share in cash.

More... »

BioClinica Buys TranSenda, Adds CTMS to Service Offerings

Monday, April 5, 2010 06:52 AM

BioClinica continued to grow its burgeoning eClinical division with the acquisition of clinical trial management software (CTMS) company TranSenda for an estimated $2.5 million.

More... »

BioClinica, Health Decisions Broaden CRO Networks

Thursday, March 18, 2010 07:42 AM

BioClinica added two contract research organizations (CROs)—Health Sciences International and PRL Central Laboratory Services—to its Certified Partner Program, a group established by the CRO to broaden its service offerings. 

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs